The week in review

It’s been a busy week in community pharmacy, with renewed conflict with GPs and more calls for real time monitoring and a national vaccination approach

GPs continue to oppose pharmacy initiatives, this time with the AMA‘s Dr Tony Bartone labelling a TerryWhite Chemmart/Bupa partnership a “crass commercialisation of primary health care”. And the RACGP‘s Dr Harry Nespolon claimed the public were losing trust in pharmacists, due to their sales of complementary medicines.

Meanwhile the Pharmacy Guild spoke out about last week’s mainstream media coverage of discount scripts and the location rules, saying that the organisation had been “misrepresented and misquoted” in News Corp media. Executive director Pam Price called again for the Guild’s proposed across-the-board $1 copay reduction, funded by government.

There have been yet more calls for real time monitoring, including a cohesive national system, from a coroner in the ACT, and the South Australian branch of the PSA. The PSA also called for a national approach to pharmacist vaccination, following the release of a study looking at 13 Victorians who had received a dose of measles vaccine, but later caught the disease.

There was a new enterprise agreement for HPS pharmacists and another for National Pharmacies employees. AHPRA released a video outlining what it’s like to receive a notification; while PDL issued guidance on milligrams versus millilitres and staged supply.

And the TGA issued advice that hundreds of medicine ingredients will have their names changed in 2020 (not to the delight of some AJP readers, as it turned out).

Previous The cost of burnout
Next Jail time over poisoning

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply